Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1419 | Ulixertinib | 0.003162278 | 1.0355 | -0.00386 |
| HCC1419 | Ulixertinib | 0.01 | 0.9003 | -0.00550 |
| HCC1419 | Ulixertinib | 0.01 | 1.0147 | 0.01318 |
| HCC1419 | Ulixertinib | 0.01 | 1.1125 | -0.00811 |
| HCC1419 | Ulixertinib | 0.031622777 | 0.8955 | -0.00223 |
| HCC1419 | Ulixertinib | 0.031622777 | 0.9649 | 0.00659 |
| HCC1419 | Ulixertinib | 0.031622777 | 0.9491 | -0.00579 |
| HCC1419 | Ulixertinib | 0.1 | 1.0873 | -0.00054 |
| HCC1419 | Ulixertinib | 0.1 | 1.1120 | -0.00015 |
| HCC1419 | Ulixertinib | 0.1 | 0.9612 | 0.00204 |
| HCC1419 | Ulixertinib | 0.316227766 | 0.8650 | -0.00368 |
| HCC1419 | Ulixertinib | 0.316227766 | 0.9775 | -0.00233 |
| HCC1419 | Ulixertinib | 0.316227766 | 1.0966 | -0.00104 |
| HCC1419 | Ulixertinib | 1.0 | 0.7162 | 0.00470 |
| HCC1419 | Ulixertinib | 1.0 | 1.0147 | 0.00302 |
| HCC1419 | Ulixertinib | 1.0 | 1.0194 | -0.00386 |
| HCC1419 | Ulixertinib | 3.16227766 | 0.6891 | -0.00140 |
| HCC1419 | Ulixertinib | 3.16227766 | 1.1207 | -0.00733 |
| HCC1419 | Ulixertinib | 3.16227766 | 0.8236 | 0.00717 |
| HCC1419 | Ulixertinib | 10.0 | 0.6070 | 0.00822 |
| HCC1419 | Ulixertinib | 10.0 | 0.5776 | 0.00706 |
| HCC1419 | Ulixertinib | 10.0 | 0.6946 | 0.00050 |
| HCC1419 | Alvocidib | 0.0001 | 1.1161 | -0.00419 |
| HCC1419 | Alvocidib | 0.0001 | 0.8586 | -0.00137 |
| HCC1419 | Alvocidib | 0.0001 | 1.0656 | -0.00825 |